期刊文献+

重视循证研究进展 规范胃癌综合治疗 被引量:2

Standardization of the treatment of gastric cancer with the advance of evidence based medicine
原文传递
导出
摘要 循证医学是临床医学的新模式,正不断改变着临床医师的理念和实践。虽然针对胃癌治疗的临床研究已很深入,并发挥了重要的作用,但是其结论并不相同,也各有其局限性。临床医师在治疗胃癌病人过程中,应合理运用循证依据,并结合病人自身情况,制定个体化治疗方案。 Evidence based medicine has emerged as a new mode of clinical medicine, and changed the concepts and practice of doctors. Though some high-level clinical trials have been carried out, and their results made great progress in the field of treatment of gastric cancer, the protocols of the trials have some limitation and the results are not identical. During the treatment for patients with gastric cancer, doctors should properly apply the evidences and consider the conditions of such patients, then make individualized treatment regimen.
出处 《中国实用外科杂志》 CSCD 北大核心 2011年第8期643-644,651,共3页 Chinese Journal of Practical Surgery
关键词 胃癌 循证医学 辅助治疗 gastric cancer evidence based medicine adjuvant therapy
  • 相关文献

参考文献7

  • 1孙益红.胃癌术前和术后化疗的应用及评价[J].中国实用外科杂志,2009,29(9):777-778. 被引量:6
  • 2Songun I,,Putter H,Kranenbarg EM,et al.Surgical treatment of gastric cancer:15-year follow-up results of the randomised nationwide Dutch D1D2trial. The Lancet Oncology . 2010
  • 3Sasako M,Sano T,Yamamoto S,et al.2</sub> lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer&amp;sid=The New England Journal of Medicine&amp;aufirst=Sasako M');&#xA; ">D<sub>2</sub> lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. The New England Journal of Medicine . 2008
  • 4Nashi moto A,Nakaji ma T,Furukawa H,et al.Randomized trial of adjuvant chemotherapy with mitomycin,fluorouracil,and cy-tosine arabinoside followed by oral fluorouracil in serosa-nega-tive gastric cancer:Japan Clinical Oncology Group9206-1. Journal of Clinical Oncology . 2003
  • 5Macdonald J S,Smalley S R,Benedetti J,et al.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. The New England Journal of Medicine . 2001
  • 6Sakuramoto S,Sasako M,Yamaguchi T,et al.Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. New England Journal of Medicine, The . 2007
  • 7Cunningham D,Allum WH,Stenning SP,et al.Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Homeopathy . 2006

二级参考文献8

  • 1Hermans J, Bonenkamp J J, Be, on MC, et al. Adjuvant therapy after curative resection for gastric cancer. A meta-analysis of randomized trials [J]. J Clin Oncol, 1993,11(8): 1441-1447.
  • 2Earle C, Maroun J. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials [J]. EurJ Cancer, 1999,35(7): 1059-1064.
  • 3Mari E, Floriani I, Tinazzi A, et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer. A recta-analysis of published randomised trials [J]. Ann Oncol, 2000,11(7): 837-843.
  • 4Panzini I, Gianni L, Fattori PP, et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses [J]. Turnoff, 2002, 88(1): 21-27.
  • 5Liu TS, Wang Y, Chen SY, et al. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer [ J ]. Eur J Surg Oncol, 2008,34(1 1): 1208-1216.
  • 6Sakuramolo S, Sasako M, Katai H, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimldine [J]. N Engl J Med, 2007, 357(18): 1810-1820.
  • 7Ajani JA, Winter K, Okawara GS, el at. Phase II trial of preoperative chemoradiation in patients with loe, alized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response [J]. J Clin Oncnl, 2006, 24(24): 3953-3958.
  • 8Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastraesophageal cancer[J]. N Engl J Med, 2006, 355(1): 11-20.

共引文献5

同被引文献24

  • 1蔡伟萍,黄叶莉.癌症疼痛护理的研究进展[J].护理管理杂志,2005,5(6):11-13. 被引量:69
  • 2MacDermid E,Hooton G,MacDonald M,et al.Improving patientsurvival with the colorectal cancer multi-disciplinary team[J].Colorectal Dis,2009,11(3):291-295.
  • 3Whitehouse M.A policy framework for commissioning cancerservices[J].BMJ,1995,310(6992):1425-1426.
  • 4van Leeuwen AF,Voogt E,Visser A,et al.Considerations ofhealthcare professionals in medical decision-making about treatmentfor clinical end-stage cancer patients[J].J Pain SymptomManage,2004,28(4):351-355.
  • 5van Nes JG,van de Velde CJ.The multidisciplinary breast cancercare team: promoting better care [J].Ned Tijdschr Geneeskd,2005,149(35):1929-1931.
  • 6Cai J,Wei D,Gao CF,et al.A prospective randomized studycomparing open versus laparoscopy-assisted D2 radical gastrectomyin advanced gastric cancer[J].Dig Surg,2011,28(5-6):331-337.
  • 7Moisan F,Norero E,Slako M,et al.Completely laparoscopic versusopen gastrectomy for early and advanced gastric cancer: amatched cohort study[J].Surg Endosc,2011,26(3):661-672.
  • 8Coratti A,Annecchiarico M,Di Marino M,et al.Robot-assistedgastrectomy for gastric cancer: current status and technical considerations[J].World J Surg,2013,37(12):2771-2781.
  • 9Songun I,Putter H,Kranenbarg EM,et al.Surgical treatment ofgastric cancer: 15-year follow-up results of the randomised nationwideDutch D1D2 trial [J].Lancet Oncol,2010,11(5):439-449.
  • 10Jiang L,Yang KH,Guan QL,et al.Survival and recurrence freebenefits with different lymphadenectomy for resectable gastriccancer: a meta-analysis [J].J Surg Oncol,2013,107(8):807-814.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部